First Personalized Gene Therapy Using Base Editing Shows Promising Results in Baby with Rare Disorder
- A baby named KJ Muldoon from Clifton Heights, Pennsylvania, received a personalized gene editing therapy for severe CPS1 deficiency and is now growing well.
- Doctors developed this treatment quickly using CRISPR to fix a critical genetic error that kills half of affected infants, addressing a condition affecting about one in a million babies.
- The lipid nanoparticle-delivered therapy involved additional doses, enabling KJ to resume a more typical diet and demonstrate strong recovery from illnesses despite the challenges posed by CPS1.
- Researchers noted the $800,000-plus cost was comparable to a liver transplant and expect expenses to decrease as production improves, with hopes to help the millions left behind by current treatments.
- Experts said this case, published in the New England Journal of Medicine, represents a first step toward wider gene editing therapies for rare disorders despite existing barriers.
236 Articles
236 Articles
Washington Should Fund More Potential Science Miracles
A baby boy, born in Philadelphia in 2024 with a potentially fatal genetic deficiency, has become the first person treated with a custom gene-editing therapy. Doctors used CRISPR technology to rapidly create a personalized treatment for KJ, targeting the child’s specific mutation. The boy is meeting developmental milestones, his weight is in the 40th percentile, but his need for a liver transplant is still unknown, according to news reports. This…
From birth to gene-edited in 6 months: Custom therapy breaks speed limits
News broke yesterday that researchers in Philadelphia appear to have successfully treated a 6-month-old baby boy, called KJ, with a personalized CRISPR gene-editing therapy. The treatment corrects an ultra-rare mutation in KJ that breaks a liver enzyme. That enzyme is required to convert ammonia, a byproduct of metabolism, to urea, a waste product released in urine. Without treatment, ammonia would build up to dangerous levels in KJ—and he would…
World's first successful tailor-made gene therapy saves baby born with rare disorder
Baby KJ Muldoon was born with a rare genetic condition that is often fatal, but doctors used custom CRISPR gene therapy to target the exact mutation in his DNA. His family shares their emotional journey in their first TV interview with CBS News.
Coverage Details
Bias Distribution
- 59% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage